Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
The experimental setup exposed dermal fibroblasts to various combinations of GHK-Cu and HA
Theres a lot of mixed information out there, making it hard to separate fact from fiction
Where they overlap and where they don't Complementary Mechanism Targets Target Origin BPC-157 Gastric juice protein fragment (15 amino acids) TB-500 Thymosin Beta-4 fragment (LKKTETQ region) Target Primary action BPC-157 Local tissue repair signaling TB-500 Systemic cell migration and mobilization Target Angiogenesis BPC-157 VEGF upregulation, NO pathway TB-500 Endothelial migration, VEGF crosstalk Target Cell migration BPC-157 Indirect, via growth factors TB-500 Direct (G-actin sequestering) Target Best-evidence tissue BPC-157 Tendon, gut, gastric mucosa (preclinical) TB-500 Cardiac, corneal, skin (preclinical + early human T4) Target Reported in vivo half-life BPC-157 ~4 hours (animal estimates) TB-500 ~23 days (animal estimates) Half-life figures are pharmacokinetic estimates from animal studies
Bone Miner
US$ 23.22
US$ 23.33
US$ 21.69
US$ 29.82
